The association between in vivo central noradrenaline transporter (cas 136253-20-8) availability and trait impulsivity

Add time:08/30/2019    Source:sciencedirect.com

The brain noradrenaline (NA) system, particularly NA transporters (NAT), are thought to play an important role in modulating impulsive behavior. Impaired impulsivity is implicated in a variety of neuropsychiatric conditions; however, an in vivo link between central NAT availability and human impulsivity has not been shown. Using positron emission tomography (PET) and S,S-[11C]O-methylreboxetine (MRB), we tested whether NAT availability is associated with this basic behavioral trait based on the Barratt Impulsiveness Scale (BIS-11) in twenty healthy individuals (12 females, 33.8±9.3, 21–52 years of age) with a body mass index (BMI) ranging from 21.7 kg/m2 to 47.8 kg/m2. Applying both voxel-wise and volume-of-interest (VOI) based analyses, we found that distribution volume ratios (DVR) used as PET outcome measures negatively correlated with BIS-11 total scores in the orbitofrontal cortex (OFC) and in the hippocampus as well as in parts of the cerebellar cortex. These associations however did not remain after correction for multiple testing. Thus, although it appears that low NAT availability is associated with greater scores of impaired behavioral control, this needs to be confirmed in a larger series of individuals with highly impulsive behavior.

We also recommend Trading Suppliers and Manufacturers of noradrenaline transporter (cas 136253-20-8). Pls Click Website Link as below: cas 136253-20-8 suppliers

Prev:Arsenic adsorption using copper (II) oxide nanoparticles
Next:New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter (cas 136253-20-8))